HPV Infections: Diagnosis, Prevention, and Treatment

Preclinical and Clinical Experiments on HPV Vaccines

Author(s): Azam Bolhassani and Afshin Khavari

Pp: 201-214 (14)

DOI: 10.2174/116010017

* (Excluding Mailing and Handling)


Persistent infection with human papillomavirus (HPV) is a key factor in the development of precancerous lesions and invasive cervical cancer. Prophylactic vaccines are an effective approach to reduce HPV-related disease burden. Regarding the studies, at least 110-120 countries have implemented Cervarix™ and Gardasil™ for induction of protective effects against HPV infections. On the other hand, several clinical trials are underway for therapeutic HPV vaccination. Special approaches is considered to increase the potency of therapeutic vaccines including the use of effective adjuvant, selection of strong immunogen and combination therapies to overcome tumor immune suppression. In this chapter, we will summarize main preventive and therapeutic HPV vaccines in preclinical and clinical trials.

Keywords: Clinical study, HPV infection, Preclinical study, Prophylactic vaccine, Therapeutic vaccine.Clinical study, HPV infection, Preclinical study, Prophylactic vaccine, Therapeutic vaccine.

Related Journals
Related Books
© 2024 Bentham Science Publishers | Privacy Policy